[Calcium antagonists and blood filterability].
Muggia
C
C
Ranieri
M G
MG
Bobba
L
L
Testa
F
F
Martignoni
A
A
Perani
G
G
Finardi
G
G
D000328:Adult; D000368:Aged; D002121:Calcium Channel Blockers / Q000494:pharmacology*; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D004907:Erythrocyte Deformability / Q000187:drug effects*; D005260:Female; D006801:Humans; D006973:Hypertension / Q000097:blood / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D009543:Nifedipine / Q000494:pharmacology / Q000627:therapeutic use; D011437:Propylamines / Q000494:pharmacology / Q000627:therapeutic use; D011897:Random Allocation; D013976:Tiapamil Hydrochloride
D002121:Calcium Channel Blockers; D011437:Propylamines; D009543:Nifedipine; D013976:Tiapamil Hydrochloride
Calcioantagonisti e filtrabilità ematica.